tradingkey.logo

MacroGenics Inc <MGNX.OQ> expected to post a loss of 78 cents a share - Earnings Preview

ReutersMay 9, 2025 9:57 PM
  • MacroGenics Inc MGNX.OQ MGNX.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • The Rockville Maryland-based company is expected to report a 32.3% decrease in revenue to $6.167 million from $9.1 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for MacroGenics Inc is for a loss of 78 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 13.2% in the last three months. ​

  • Wall Street's median 12-month price target for MacroGenics Inc is $6.00​, above​ its last closing price of $1.54. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.44

-0.25

Beat

42.7

Sep. 30 2024

0.11

0.21

0.90

Beat

324.5

Jun. 30 2024

-0.54

-0.59

-0.89

Missed

-51.2​

Mar. 31 2024

-0.64

-0.64

-0.84

Missed

-30.7

​​Dec. 31 2023

-0.26

-0.15

-0.75

Missed

-388

Sep. 30 2023

-0.06

-0.10

0.28

Beat

392.9​

Jun. 30 2023

-0.47

-0.52

-0.69

Missed

-32.4

Mar. 31 2023

0.42

0.45

-0.61

Missed

-234.9

This summary was machine generated May 9 at 21:57 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI